Portal de Periódicos da CAPES

Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

2016; Elsevier BV; Volume: 16; Issue: 3 Linguagem: Inglês

10.1016/j.clcc.2016.08.002

1938-0674

Dinçer Aydın, Mehmet Alı Nahıt Şendur, Umut Kefeli, Olçun Ümit Ünal, Didem Taştekin, Murat Akyol, Eda Tanrıkulu, Aydın Çiltaş, Bala Başak Öven Ustaalıoğlu, Mükremın Uysal, Onur Esbag, Doğan Yazılıtaş, Özgür Tanrıverdi, Ahmet Bılıcı, Erkan Arpacı, Velı Berk, Tarkan Yetişyiğit, Nuriye Özdemir, İlhan Öztop, Ahmet Alacacıoğlu, Özhan Aydin, Melike Özçelik, Emre Yıldırım, Nur Dinç, Mahmut Gümüş,

Colorectal Cancer Surgical Treatments

Small bowel adenocarcinoma (SBA) is a rare tumor of the gastrointestinal system with poor prognosis. Because these are rarely encountered tumors, the aim of this multicenter study was evaluation of prognostic factors and adjuvant chemotherapy in patients with curatively resected SBA.A total of 78 patients diagnosed with curatively resected SBA were involved in the retrospective study. Forty-eight patients received 1 of 3 different chemotherapy regimens, whereas 30 patients did not receive any adjuvant treatment. No adjuvant and adjuvant chemotherapy cohorts were matched (1:1) by propensity scores based on the likelihood of receiving chemotherapy or the survival hazard from Cox modeling. Overall survival (OS) was compared with Kaplan-Meier estimates.Median age of 78 patients with curatively resected SBA was 58, and 59% of these were men. According to TNM classification, 8 (10%) of the patients were at stage I, 26 (34%) were at stage II, and 44 (56%) were at stage III. Median follow-up duration was 29 months. Three-year median disease-free survival (DFS) and OS were 62.5% and 67.0%, respectively. In univariate analysis, presence of vascular invasion, perineural invasion, lymph node involvement, and presence of positive surgical margin were significant predictors of poor survival. Multivariate analysis showed that the only adverse prognostic factor independently related with OS was the presence of positive surgical margin (hazard ratio, 0.37; 95% confidence interval, 0.11-1.26; P = .01). Neither DFS nor OS was found to be significantly improved by the adjuvant chemotherapy in both matched and unmatched cohorts.Only status of surgical margin was determined to be an independent prognostic factor in patients with SBA who underwent curative resection.